PT Sejahteraraya Anugrahjaya Tbk (ISX:SRAJ) Research & Development: Rp0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SRAJ PT Sejahteraraya Anugrahjaya Tbk ISX:SRAJ
63 GF Score
Price Rp11,000.00
GF Value Rp2,684.15
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is PT Sejahteraraya Anugrahjaya Tbk Research & Development?

PT Sejahteraraya Anugrahjaya Tbk ISX:SRAJ 63 Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus rates ISX:SRAJ with a GF Score™ of 63/100 and a GF Value™ of Rp2,684.15 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Sejahteraraya Anugrahjaya Tbk's Research & Development for the three months ended in Mar. 2026 was Rp0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was Rp0 Mil.

PT Sejahteraraya Anugrahjaya Tbk  (ISX:SRAJ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Sejahteraraya Anugrahjaya Tbk Research & Development Related Terms

PT Sejahteraraya Anugrahjaya Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Sejahteraraya Anugrahjaya Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Sejahteraraya Anugrahjaya Tbk Research & Development Chart

PT Sejahteraraya Anugrahjaya Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PT Sejahteraraya Anugrahjaya Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:SRAJ
63GF Score
PT Sejahteraraya Anugrahjaya Tbk ISX:SRAJ
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Sejahteraraya Anugrahjaya Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp0 Mil mean?
PT Sejahteraraya Anugrahjaya Tbk (ISX:SRAJ) has a Research & Development of Rp0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on PT Sejahteraraya Anugrahjaya Tbk and its competitors.
Is PT Sejahteraraya Anugrahjaya Tbk's Research & Development too high?
PT Sejahteraraya Anugrahjaya Tbk's current Research & Development is Rp0 Mil. Overall, PT Sejahteraraya Anugrahjaya Tbk has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Sejahteraraya Anugrahjaya Tbk's Research & Development compare to HCA and THC?
PT Sejahteraraya Anugrahjaya Tbk's Research & Development of Rp0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Sejahteraraya Anugrahjaya Tbk and its competitors. PT Sejahteraraya Anugrahjaya Tbk's current Research & Development is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Sejahteraraya Anugrahjaya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Sejahteraraya Anugrahjaya Tbk (ISX:SRAJ) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp2,684.15, compared to a current price of Rp11,000.00 — trading 309.8% above its estimated fair value. The current Research & Development is Rp0 Mil. PT Sejahteraraya Anugrahjaya Tbk's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Sejahteraraya Anugrahjaya Tbk (ISX:SRAJ), the current Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Sejahteraraya Anugrahjaya Tbk (ISX:SRAJ) Overvalued in 2026?

Based on GuruFocus' analysis, PT Sejahteraraya Anugrahjaya Tbk stock appears to be overvalued. The current stock price of Rp11,000.00 is trading 309.8% above its estimated GF Value™ of Rp2,684.15. GuruFocus considers PT Sejahteraraya Anugrahjaya Tbk to be Significantly Overvalued.

Key valuation signals for ISX:SRAJ:

  • Research & Development: Rp0 Mil
  • GF Value™: Rp2,684.15 vs. price of Rp11,000.00 (309.8% above fair value)
  • GF Score™: 63/100 with 1 warning sign

No single metric tells the full story. See the ISX:SRAJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Sejahteraraya Anugrahjaya Tbk Business Description

Address Jalan Honoris Raya Kav. 6, Kota Modern (Modernland), Kelapa Indah, Banten, Tangerang, IDN, 15117
PT Sejahteraraya Anugrahjaya Tbk operates hospitals and offers health care services. The company provides healthcare services encompassing medical services, supporting medical services, outpatient care, inpatient care, and emergency services. In addition, the company also delivers hospital management and operational services. It classifies its revenues into two main business activities, namely inpatient services and outpatient services. The majority of revenue is derived from the inpatient services business. The company is divided into four geographical areas: namely DKI Jakarta, Banten, West Java, and East Java.
63GF Score

Get the complete analysis for ISX:SRAJ

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp11,000.00
Price
Rp2,684.15
GF Value